Bottom line
HIBS vs PILL: the short answer
HIBS (Direxion Daily S&P 500(R) High Beta Bear 3X ETF) and PILL (Direxion Daily Pharmaceutical & Medical Bull 3X ETF) are quite different portfolios: only about 37% of their top holdings (by weight) are shared.
But PILL is far broader, holding 73 positions to 8 for HIBS, so beyond the top names it adds exposure HIBS doesn't have.
PILL is cheaper at 0.98% vs 1.06% — a difference of $8.00 a year per $10,000 invested.
Over five years, PILL returned −12.6% a year vs −55.6% for HIBS.
Updated Nov 19, 2026
HIBS vs PILL side by side
| HIBS | PILL | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Direxion | Direxion |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 1.06% | 0.98% |
| Annual cost per $10k | $106 | $98 |
| 10-yr cost on $10k (prospectus) | $1,347 | $1,456 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | −72.4% | +75.0% |
| 5-yr return (annualized) | −55.6% | −12.6% |
| 10-yr return (annualized) | — | — |
| Best quarter | +74.7% | +103.7% |
| Worst quarter | −79.0% | −61.4% |
| Net assets (fund) | $22.6M | $20.7M |
| Number of holdings | 8 | 73 |
| Portfolio turnover | % | 88% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | HIBS | PILL | Difference |
|---|---|---|---|
| 2025 | −72.4% | +75.0% | −147.4% |
| 2024 | −26.6% | −6.9% | −19.7% |
| 2023 | −63.0% | −12.7% | −50.3% |
| 2022 | −7.6% | −43.1% | +35.5% |
| 2021 | −75.2% | −37.2% | −38.1% |
| 2020 | −91.6% | −0.3% | −91.3% |
Source: Fund prospectus bar charts
Holdings overlap
8 of HIBS's top 8 holdings also appear in PILL's top 25.
| Holding | HIBS | PILL |
|---|---|---|
| Dreyfus | 48.43% | 8.14% |
| Goldman Financial | 28.96% | 22.36% |
| Goldman Sachs Liq Es Fd A | 26.65% | 2.03% |
| N/a | 5.90% | 7.41% |
| N/a | 2.40% | 7.41% |
| N/a | 2.21% | 7.41% |
| N/a | 1.19% | 7.41% |
| N/a | 1.18% | 7.41% |
Source: SEC Form N-PORT
HIBS top 10
- Dreyfus — 48.43%
- Goldman Financial — 28.96%
- Goldman Sachs Liq Es Fd A — 26.65%
- N/a — 5.90%
- N/a — 2.40%
- N/a — 2.21%
- N/a — 1.19%
- N/a — 1.18%
PILL top 10
- Goldman Financial — 22.36%
- N/a — 16.36%
- Dreyfus — 8.14%
- N/a — 7.41%
- Crinetics Pharmaceuticals In — 2.77%
- Mbx Biosciences Inc — 2.42%
- Ataibeckley Inc — 2.16%
- Definium Therapeutics, Inc — 2.13%
- Goldman Sachs Liq Es Fd A — 2.03%
- Amylyx Pharmaceuticals Inc — 1.72%
FAQ
What is the difference between HIBS and PILL?
Which is cheaper, HIBS or PILL?
Should I own both HIBS and PILL?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.